CK Isoforms

  • Sol F. Green
Part of the Pathology and Laboratory Medicine book series (PLM)


In 1985, the TIMI* study group (1) conducted a 5-yr multicenter trial. The study concluded that patients with acute myocardial infarction (AMI) received maximum benefits when they received thrombolytic therapy within 4–6 h after onset of chest pain. Therefore, an early biochemical marker of AMI is crucial in diagnosis of myocardial injury. Currently, CK-MB isoforms are the only cardiac-specific markers satisfying these criteria, although other markers are being developed (see Chapter 17). The proceeding discussion is focused on review of pertinent biochemistry, approaches to analytical measurements, and the clinical applications of CK isoforms.


Acute Myocardial Infarction Creatine Kinase Acute Myocardial Infarction Thrombolytic Therapy Serum Form 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    TIMI Study Group (1985) The thrombolysis in acute myocardial infarction (TIMI) trial. N. Engl. J. Med. 312:932–936.Google Scholar
  2. 2.
    Smith AF (1972) Separation of tissue and serum creatine kinase isoenzymes on poly-acrylamide gel slabs. Clin. Chim. Acta. 39: 351–359.PubMedCrossRefGoogle Scholar
  3. 3.
    George S, Ishikawa Y, Perryman MB, and Roberts R (1984) Purification and characterization of naturally occurring and in vitro induced multiple forms of creatine kinase. J. Biol. Chem. 259:2667–2674.PubMedGoogle Scholar
  4. 4.
    Perryman MB, Knell JD, and Roberts R (1984) Carboxypeptidase-catalyzed hydrolysis of C-terminal lysine; mechanism for in vivo production of multiple forms of creatine kinase in plasma. Clin. Chem. 30: 662–664.PubMedGoogle Scholar
  5. 5.
    Panteghini M (1988) Serum isoforms of creatine kinase isoenzymes. Clin. Biochem. 21:211–218.PubMedCrossRefGoogle Scholar
  6. 6.
    Wu AHB (1989) Creatine kinase isoforms in ischemic heart disease [Review]. Clin. Chem. 35:7–13.PubMedGoogle Scholar
  7. 7.
    Schweisfurth H, Schmidt M, Brugger E, Maiwald L, and Thiel H (1985) Alterations of serum carboxypeptidases N and angiotensin-I-converting enzyme in malignant diseases. Clin. Biochem. 18:242–246.PubMedCrossRefGoogle Scholar
  8. 8.
    Schweisfurth H, Pickert E, Gramer E, and Reiners C (1987) Alterations of carboxypeptidases N activities in patients with thyroid disease. Clin. Biochem. 20:43–46.PubMedCrossRefGoogle Scholar
  9. 9.
    Wevers RA, Hagelauer U, Stein W, Bohner J, Faust U, van Landeghem AAJ, and Soons JBJ (1985) Indicies for the age of the creatine kinase M-chain in the blood. Clin. Chim. Acta 148:197–210.PubMedCrossRefGoogle Scholar
  10. 10.
    Wevers RA, Delsing M, Klein Gebbink JAG, and Soons JBJ (1978) Post-synthetic changes in creatine kinase isozyme. Clin. Chem. Acta. 86:323–327.CrossRefGoogle Scholar
  11. 11.
    Green S and Wu A (1993) Immunoassays and electrophoresis for creatine kinase isoenzymes and isoforms in diagnosis and management of acute myocardial infarction. AACC Endo. Metabol. 11:329–344.Google Scholar
  12. 12.
    Prager NA, Suzuki T, Jaffe AS, Sobel BE, and Abendschein DR (1992) The nature and time course of generation of the isoforms of MB creatine kinase in vivo. J. Am. Coll. Car-diol. 20:414–419.CrossRefGoogle Scholar
  13. 13.
    Nguyen TM, Cartwright AJ, Osborne M, and Morris GE (1991) Structural changes in the C-terminal region of human brain creatine kinase studied with monoclonal antibodies. Biochim. Biophys. Acta. 1076:245–251.CrossRefGoogle Scholar
  14. 14.
    Grace AM, Strauss AW, and Sobel BE (1985) Sensitive quantification of isoforms of canine MM creatine kinase with an immunblot procedure suitable for large numbers of samples. Anal. Biochem. 149:209–217.PubMedCrossRefGoogle Scholar
  15. 15.
    Chapelle JP and Hensghem C (1980) Further heterogeneity demonstrated for serum creatine kinase isoenzyme MM. Clin. Chem. 26:457–462.PubMedGoogle Scholar
  16. 16.
    Kanemitsu F and Okigaki T (1994) Characterization of human creatine kinase BB and MB isoforms by means of isoelectric focusing. Clin. Chem. Acta. 231:1–9.CrossRefGoogle Scholar
  17. 17.
    Nohara R, Sobel BE, Jaffe AS and Abendschein DR (1988) Quantitative analysis of isoforms of MM creatine kinase in plasma by chromatofocusing with on-line monitoring of enzyme activity. Clin. Chem. 34:235–239.PubMedGoogle Scholar
  18. 18.
    Hashimoto H, Grace AM, Billadelo JJ, Gross RW, Strauss AW, and Sobel BE (1984) Nondenaturing quantification of sub-forms of canine MM creatine kinase (isoforms) and their interconversion. J. Lab. Clin. Med. 103:470–484.PubMedGoogle Scholar
  19. 19.
    Schlabach TD, Alpert AJ, and Regnier FE (1978) Rapid assessment of isoenzymes by high performance liquid chromatography. Clin. Chem. 24:1351–1360.PubMedGoogle Scholar
  20. 20.
    Bhayana V, Cohoe S, and Henderson AR (1995) Evaluation of the cardio rep for creatine kinase isoforms analysis. Clin. Chem. 41:S184.Google Scholar
  21. 21.
    Laurino JP, Fischberg-Bender E, and Chang J (1995) An immunochemical mass assay for the direct measurement of creatine kinase MB2. Ann. Clin. Lab. Sci. 25:252–263.PubMedGoogle Scholar
  22. 22.
    Laurino JP, Bender EW, Kessimian N, Chang J, Pelletier T, and Usategui M (1996) Comparative sensitivities and specificities of the mass measurements of CK-MB2, CK-MB, and myoglobin for diagnosing acute myocardial infarction. Clin. Chem. 42:1454–1459.PubMedGoogle Scholar
  23. 23.
    Davies J, Reynolds T, and Penney MD (1992) Creatine kinase isoforms: investigation of inhibitors of in-vitro degradation and establishment of a reference range. Ann. Clin. Biochem. 29:202–205.PubMedGoogle Scholar
  24. 24.
    Chapelle JP (1984) Serum creatine kinase MM sub-band determination by isoelectric focusing: a potential method for the moni-toring of myocardial infarction. Clin. Chim. Acta. 137:273–281.PubMedCrossRefGoogle Scholar
  25. 25.
    Morelli RL, Emilson B, and Rapaport E (1987) MM-CK subtypes diagnose reperfu-sion early after myocardial infarction. Am. J. Med. Sci. 293:139–149.PubMedCrossRefGoogle Scholar
  26. 26.
    Jaffe AS, Serota H, Grace A, and Sobel B (1986) Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. Circulation 74: 105–109.PubMedCrossRefGoogle Scholar
  27. 27.
    Morelli RL, Calson CJ, Emilson B, Abendschein DR, and Rapaport E (1983) Serum creatine kinase MM isoenzyme sub-bands after acute myocardial infarction in man. Circulation 67:1283–1289.PubMedCrossRefGoogle Scholar
  28. 28.
    Keshgegian AA, Bhagat PK, Lease J, and Balocchi J (1988) Creatine kinase MM isoforms in serum after cardiac surgery. Clin. Chem. 34:1067–1070.PubMedGoogle Scholar
  29. 29.
    Serena C, Stefini F, Turia C, Pagani F, and Panteghini M (1995) Evaluation of cardio rep analyzer for creatine kinase MB isoforms determination. 27 Congresso Nazionale della Societa Italiana di Biochim-ica Clinica, Riva del Garda (TN).Google Scholar
  30. 30.
    Peterson, E (1996) Personal communication, Helena Laboratories, Beaumont, TX.Google Scholar
  31. 31.
    Suzuki T, Shiraishi T, Tomita K, Totani M, and Murachi T (1990) Monoclonal antibody inhibiting creatine kinase MM3 but not isoform MM1. Clin. Chem. 36: 153–156.PubMedGoogle Scholar
  32. 32.
    Wu AHB, Gornet TG, Wu VH, Brockie RE, and Nishikawa A (1987) Early diagnosis of acute myocardial infarction by rapid analysis of creatine kinase isoenzyme-3 (CK-MM) subtypes. Clin. Chem. 33:358–362.PubMedGoogle Scholar
  33. 33.
    Armbrustwer DA (1991) The genesis and clinical significance of creatine kinase isoforms [Review]. Lab. Med. 22:325–334.Google Scholar
  34. 34.
    Yang XS and Meng QY (1993) Serum iso-forms of creatine kinase MM isoenzyme in acute myocardial infarction. Clin. Med. J. 106:410–414.Google Scholar
  35. 35.
    Wu AHB (1992) Creatine kinase MM and MB isoforms. Lab. Med. 23:303–305.Google Scholar
  36. 36.
    Puleo PR, Guadagno PA, Roberts R, Perryman MB (1989) Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin. Chem. 35:1452–1455.PubMedGoogle Scholar
  37. 37.
    Puleo PR, Guadagno PA, and Roberts R (1990) Early diagnosis of acute myocardial infarction based on an assay for subforms of creatine kinase-MB. Circulation 82: 759–764.PubMedCrossRefGoogle Scholar
  38. 38.
    Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, Ljungdahl L, and Lofdahl P (1991) S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin. Chem. 37:1405–1411.PubMedGoogle Scholar
  39. 39.
    Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, and Puschendorf B (1995) Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin. Chem. 41:1266–1272.PubMedGoogle Scholar
  40. 40.
    Collinson PO, Rosalki SB, Kuwana T, Garratt HM, Ramhamadamy EM, Baird M, and Greenwood TW (1992) Early diagnosis of acute myocardial infarction by CK-MB mass measurements. Ann. Clin. Biochem. 29:43–47.PubMedGoogle Scholar
  41. 41.
    Bhayana V, Cohoe S, Leung F, Jablansky G, and Henderson R (1993) Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and-2 isoform ratios in early diagnosis of acute myocardial infarction. Clin. Chem. 39:488–495.PubMedGoogle Scholar
  42. 42.
    Wu AHB, Wang X-M, Gornet TG, and Ordonez-Lianos J (1992) Creatine kinase MB isoforms in patients with myocardial infarction and skeletal muscle injury. Clin. Chem. 38:2396–2400.PubMedGoogle Scholar
  43. 43.
    Christenson R (1993) Specificity of an immunochemical reagent for quantifying the isoforms of creatine kinase-MB. J. Clin. Lab. Anal. 7:220–224.PubMedCrossRefGoogle Scholar
  44. 44.
    Bernardoni C, Pravettoni G, Besomig et al. (1995) Rapid assay of isoforms of creatine kinase MB to diagnose acute myocardial infarction (AMI). J. Suisse. Med. 29:32s.Google Scholar
  45. 45.
    Christenson RH, Clemmenson P, Ohman EM, Toffaletti J, Silverman LM, Grande P, Vollmer RT, and Wagner GS (1990) Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependant. Clin. Chem. 36: 1444–1449.PubMedGoogle Scholar
  46. 46.
    Garabedian HD, Gold HK, Yasuda T, Johns JA, Finkelstein DM, Gaivin RJ, Cobbaert C, Leinbach RC, and Collen D (1988) Detection of coronary artery reperfusion with creatine kinase MB determinations during throm-bolytic therapy: correlation with acute angiography. J. Am. Coll. Cardiol. 729–734.Google Scholar
  47. 47.
    Grande P, Gromborg J, Clemmenson P, Sevilla DC, Wagner NB, and Wagner GS (1991) Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. Am. Heart J. 122:400–408.PubMedCrossRefGoogle Scholar
  48. 48.
    Apple F (1992) Creatine kinase-MB. Lab. Med. 23:298–302.Google Scholar
  49. 49.
    Jaffe AS, Eisenberg PR, and Abendschein OR (1994) Conjoint use of MM and MB creatine kinase isoforms in detection of coronary recanalization. Am. Heart J. 127: 1461–1466.PubMedCrossRefGoogle Scholar
  50. 50.
    Schofer J, Ress-Grigolo G, Voit KD, and Mathey DG (1992) Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. Am. Heart J. 123:846–853.PubMedCrossRefGoogle Scholar
  51. 51.
    Abe S, Nomoto K, Arima S, Miyata M, Yamashita T, Naruyama I, Toda H, Okino H, Atsuchi Y, Tahava M, Nakao S, Tanaka H, and Suzuki T (1993) Detection of reperfusion 30 and 60 minutes after coronary recanalization by a rapid new assay of creatine kinase isoforms in acute myocardial infarction. Am. Heart J. 125:649–656.PubMedCrossRefGoogle Scholar
  52. 52.
    Green G, Hansen KN, Chan DW, Guerci AD, Fleetwood DH, Sivertson KT, and Kelen GD (1991) The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarction. Ann. Emerg. Med. 20:954–960.PubMedCrossRefGoogle Scholar
  53. 53.
    Puleo PR, Wathen G, Roberts R, and Perryman MB (1992) Triaging of patients with chest pain guided by MB-CK subform assay. J. Am. Coll. Cardiol. 19:303a.Google Scholar
  54. 54.
    Puleo PR, Meyer D, Wathen C, Tawa CB, Wheelers, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL, Perryman MB, and Roberts R (1994) Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N. Engl. J. Med. 331:561–566.PubMedCrossRefGoogle Scholar
  55. 55.
    Roberts R and Kleiman NS (1994) Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a “new diagnostic mind set” [Review]. Circulation 89:872–881.PubMedCrossRefGoogle Scholar
  56. 56.
    Hossein-Nia M, Kallis P, Brown PA, Chester MR, Kaski JC, Murday AJ, Tresure T, and Holt DW (1994) Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage. Clin. Chem. 40: 1265–1271.PubMedGoogle Scholar
  57. 57.
    Green G (1996) Personal communication, unpublished data.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Sol F. Green

There are no affiliations available

Personalised recommendations